Cargando…

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., Nutt, D. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813086/ https://www.ncbi.nlm.nih.gov/pubmed/29119217 http://dx.doi.org/10.1007/s00213-017-4771-x

Ejemplares similares

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression
por: Weiss, Brandon, et al.
Publicado: (2023)

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
por: Carhart-Harris, Robin L, et al.
Publicado: (2017)

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
por: Barba, Tommaso, et al.
Publicado: (2022)

Body mass index (BMI) does not predict responses to psilocybin
por: Spriggs, Meg J, et al.
Publicado: (2022)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
por: Roseman, Leor, et al.
Publicado: (2014)

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
por: Shukuroglou, Melissa, et al.
Publicado: (2022)

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
por: Stroud, J. B., et al.
Publicado: (2017)

Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment
por: Borissova, Anna, et al.
Publicado: (2020)

The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
por: Gabay, Anthony S., et al.
Publicado: (2018)

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
por: Spriggs, Meg J., et al.
Publicado: (2021)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Psilocybin: From Serendipity to Credibility?
por: Rucker, James J., et al.
Publicado: (2021)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
por: Zeifman, Richard J., et al.
Publicado: (2023)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity
por: Carhart-Harris, Robin L., et al.
Publicado: (2015)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

Spontaneous and deliberate creative cognition during and after psilocybin exposure
por: Mason, N. L., et al.
Publicado: (2021)

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
por: Schartner, Michael M., et al.
Publicado: (2017)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
por: Mason, N. L., et al.
Publicado: (2020)

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
por: Mans, Keri, et al.
Publicado: (2021)

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
por: Nygart, Victoria Amalie, et al.
Publicado: (2022)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
por: Singleton, S. Parker, et al.
Publicado: (2022)

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
por: Lyons, Taylor, et al.
Publicado: (2018)

Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?
por: Gibbons, William J., et al.
Publicado: (2021)

Effects of psilocybin-assisted therapy on treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
por: Rucker, James J, et al.
Publicado: (2022)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
por: Carhart-Harris, Robin L., et al.
Publicado: (2014)

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression
por: Lin, M. C. Q., et al.
Publicado: (2023)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
por: Forstmann, Matthias, et al.
Publicado: (2023)

Emotions and brain function are altered up to one month after a single high dose of psilocybin
por: Barrett, Frederick S., et al.
Publicado: (2020)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
por: Shah, K., et al.
Publicado: (2022)

The Therapeutic Potential of Psilocybin
por: Lowe, Henry, et al.
Publicado: (2021)

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
por: Watts, Rosalind, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p288dmfjcmi1m1pafk5clbb7gt